Kava is not classified as a drug in the United States. The FDA categorizes it as a dietary supplement, and the Drug Enforcement Administration confirms that kava is not controlled under the Controlled Substances Act. That said, kava is genuinely psychoactive. It contains compounds called kavalactones that alter brain chemistry in ways similar to some prescription medications, which is why the answer to this question depends on whether you mean “drug” in a legal sense or a pharmacological one.
How Kava Works in the Brain
Kava’s active compounds, kavalactones, interact with the same brain receptors targeted by anti-anxiety medications like benzodiazepines. These receptors respond to GABA, a chemical messenger that slows down nervous system activity and promotes relaxation. Kavain, the most abundant kavalactone, amplifies GABA’s calming signal across multiple receptor types. The effect is real and measurable: clinical trials have found that roughly 81% of people with anxiety disorders rated kava treatment as “good” or “very good,” and some researchers have described it as a viable alternative to tranquilizers without the tolerance problems that come with prescription options.
Importantly, kavain doesn’t work through the exact same binding site as benzodiazepines. It operates through a separate mechanism on the same receptor, one that overlaps more closely with how general anesthetics interact with the brain. This distinction matters because it means kava’s effects, while similar in feel to anti-anxiety drugs, aren’t identical in how they’re produced.
What Kava Intoxication Feels Like
At the small doses found in supplement capsules, kava produces mild relaxation and subtle, sometimes barely noticeable cognitive effects. Recreational use is a different story. In Pacific Island communities where kava is consumed as a traditional beverage, people drink much larger quantities. One study compared people who had consumed roughly 150 times a clinical dose over a 14-hour group session with a control group. The kava drinkers showed tremors, sedation, impaired coordination, and reduced visual attention, though their ability to perform complex thinking tasks remained surprisingly intact. The pattern suggests kava primarily disrupts movement and sensory processing rather than higher-level reasoning.
This profile of effects, sedation and motor impairment with relatively preserved cognition, is consistent with a substance acting on GABA pathways in the brain. It’s the same general category of effect produced by alcohol and benzodiazepines, though kava users often describe the experience as calmer and clearer-headed than either.
Legal Status Around the World
In the U.S., you can buy kava freely as a supplement in stores or online. No prescription is needed, and there are no federal restrictions on its sale. Australia generally classifies kava as a food or beverage, though regulations vary by state. The Northern Territory banned all forms of kava in 2020, while New South Wales lifted its own ban in 2022.
Europe has taken a harder line. Germany banned kava in 2002 after reports of liver toxicity, followed by the United Kingdom and Switzerland. France and Canada enacted similar bans. Germany reversed course in 2014, concluding that the risks were lower than initially feared and potentially less than those posed by other available treatments. The UK ban remains in place. In the European Union more broadly, kava is labeled a “herbal medicinal drug” rather than a food or supplement, placing it under stricter pharmaceutical regulation. Sweden does not permit kava as a natural medicine, and in parts of Brazil, pharmacies require a prescription to dispense it.
New Zealand occupies a gray area. Kava is widely consumed there, particularly in Pacific Islander communities, but its classification as a food, psychoactive substance, or supplement remains unclear, making consistent regulation difficult.
Liver Safety Concerns
The FDA issued a consumer advisory in 2002 warning that kava supplements may be associated with severe liver injury. This warning prompted many of the international bans. The initial theory was that the problem lay with commercial extraction methods using acetone or ethanol solvents, since traditional water-based preparations consumed in the Pacific for centuries seemed safe. Subsequent case reports reviewed by the World Health Organization undermined that theory. Liver injury has been documented with traditional water-based kava preparations as well, in New Caledonia, Australia, the U.S., and Germany.
The current thinking points toward contamination of the raw plant material rather than the preparation method itself. Poor-quality kava containing mold-produced toxins or other impurities appears more likely to cause liver problems than the kavalactones themselves. Still, any type of kava product can rarely cause liver reactions, and experts recommend water-based preparations as the safer choice when possible.
Interactions With Medications
Kava significantly interferes with the liver enzymes responsible for breaking down most pharmaceutical drugs. In laboratory testing, a standardized kava extract inhibited several major drug-metabolizing enzymes by 56% to 92%. This means kava can slow the clearance of many common medications from your body, effectively increasing their potency and raising the risk of side effects. The enzymes most heavily affected are the same ones that process a wide range of drugs, from blood thinners and anti-seizure medications to antidepressants and common pain relievers. If you take prescription medications, this interaction potential is significant and worth discussing before using kava.
Kava and Drug Testing
Kava can cause a false positive on standard urine drug screens. Kavain, the primary kavalactone, cross-reacts with at least one common immunoassay used to detect amphetamines. In three documented cases, people who had consumed only kava tested positive for amphetamine-type substances on initial screening. When the same urine samples were analyzed using more precise laboratory methods, no amphetamines were found. Only kavain was present. If you drink kava regularly and face workplace or community drug testing, a false positive is possible, though confirmatory testing would clear it.
Recommended Intake Levels
The World Health Organization has cited a daily intake of 60 to 210 mg of kavalactones as the standard range. For anxiety, the typical recommendation is 50 to 70 mg of kavalactones taken two to four times daily. As a sleep aid, 150 to 210 mg in a single dose before bed is common. Many practitioners suggest starting at the lower end and increasing gradually. These figures refer to kavalactone content specifically, not the total weight of kava powder or extract, so checking the label for kavalactone concentration matters more than the total milligrams per capsule.